日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma

烟酰胺可增强自然杀伤细胞功能,使非霍奇金淋巴瘤患者获得缓解

Frank Cichocki, Bin Zhang, Cheng-Ying Wu, Emily Chiu, Abderrahman Day, Roddy S O'Connor, Dima Yackoubov, Ronit Simantov, David H McKenna, Qing Cao, Todd E Defor, Murali Janakiram, Rose Wangen, Zuzan Cayci, Nathaniel Snyder, Akhilesh Kumar, Bartosz Grzywacz, Justin Hwang, Yona Geffen, Jeffrey S Mille

Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells

烟酰胺扩增的同种异体自然杀伤细胞(CD38 缺失,表达增强型 CD38 嵌合抗原受体)靶向多发性骨髓瘤细胞

Avishay Edri, Nimrod Ben-Haim, Astar Hailu, Nurit Brycman, Orit Berhani-Zipori, Julia Rifman, Sherri Cohen, Dima Yackoubov, Michael Rosenberg, Ronit Simantov, Hideshima Teru, Keiji Kurata, Kenneth Carl Anderson, Ayal Hendel, Aviad Pato, Yona Geffen

A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors

一项针对晚期实体肿瘤患者持续口服 OSI-906(胰岛素样生长因子 1 和胰岛素受体的双重抑制剂)的 I 期研究

Igor Puzanov, Colin R Lindsay, Laura Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T R Jeffry Evans

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

非转移性糖蛋白 B 是乳腺癌复发的独立预后指标和新的治疗靶点

April A N Rose, Andrée-Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia A Macdonald, Nicholas R Bertos, Yves St-Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M Siegel